Sitemap > Clinical Trials > GenitoUrinary Tract Disorders
- A Study To Assess If 10 mg Vardenafil (BAY 38-9456) Taken Twice Daily For 6 Weeks Has An Effect On Bladder Function
- The Efficacy, Safety And Toleration Of CP-866,087 In Pre-Menopausal Women With Female Sexual Arousal Disorder.
- The AttenueX IntraVesical System for the Treatment of Female Stress Urinary Incontinence
- Studying the Effects of 7 Days of Gonadotropin Releasing Hormone (GnRH) Treatment in Men With Hypogonadism
- Effect of Tadalafil in Chronic Obstructive Lung Disease Patients Suffering From Secondary Pulmonary Hypertension
- Efficacy and Safety Study of Combined Oral and Injection Therapy for Erectile Dysfunction
- Solifenacin Succinate With Tamsulosin HCl in Males With Lower Urinary Tract Symptoms and Bladder Outlet Obstruction
- Effect of Testosterone in Men With Erectile Dysfunction
- Long-Term Safety and Efficacy of Imidafenacin in Patients With Overactive Bladder
- Study of URG101 in Painful Bladder Syndrome and Interstitial Cystitis
- Explorative Study of Degarelix for Treatment of Benign Prostatic Hyperplasia.
- Evaluating the Effectiveness of Sertraline in Treating Women With Premenstrual Dysphoric Disorder
- Tadalafil for Treatment of Priapism in Men With Sickle Cell Anemia
- Pilot Study Investigating Safety and Efficacy of Tadalafil as Treatment for Benign Prostatic Hyperplasia in Asian Men
- Fesoterodine "Add-on" Male Overactive Bladder Study
- Alfuzosin Treatment in Children and Adolescents With Neurogenic Urinary Bladder Dysfunction
- Safety and Efficacy Study to Evaluate Proellex in the Treatment of Premenopausal Women With Symptomatic Endometriosis
- Multi-Country Observational Study to Collect the Frequency of Sexual Dysfunction With Antidepressant Treatment, Either With SSRIs or Duals at 8 Weeks and 6 Months
- A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study To Evaluate The Efficacy, Tolerability And Safety Of Fesoterodine In Comparison To Placebo In Patients With Overactive Bladder.
- SSR240600C Treatment in Women With Overactive Bladder
- Efficacy and Safety of Oral Dehydroepiandrosterone as a Concomitant Therapy to Oral Contraceptives in Women Complaining of Reduced Libido
- Yaz SH T00186D in a Flexible Extended Regimen
- SH T00186 in the Treatment of Primary Dysmenorrhea
- Study of VESIcare® In OAB Subjects to Evaluate Symptom Bother and Health Related Quality of Life (VIBRANT)
- Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder
- Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idiopathic Overactive Bladder
- Solifenacin Succinate (VESIcare) for the Treatment of Urinary Incontinence in Parkinson
- The Use of Finasteride to Reduce Hematuria and Hematospermia Following TRUS Prostate Biopsy
- Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine ER in Patients With Overactive Bladder.
- A Study to Compare 3 Different Formulations of Tamsulosin at Steady State.
- Proellex® Pharmacokinetic Bridging Study II (PK)
- A Safety and Pharmacokinetic Study of Proellex® (PK)
- A Double-Blind, Randomized, Uncontrolled Study to Evaluate Inhibition of Ovulation of Two Oral Estrogen / Progestogen Regimens in Healthy Young Female Volunteers Over a Period of 3 Treatment Cycles
- Clinical Study of Solifenacin Succinate in Patients With Bladder Symptoms Due to Spinal Cord Injury or Multiple Sclerosis (SONIC)
- Phase III Study to Assess the Efficacy and Safety of SK3530 in Patients With Erectile Dysfunction and Hypertension
- A Trial to Investigate the Effectiveness and Safety of Org 3236 (Etonogestrel) Tablets in Men With Urinary Complaints Suggestive of a Benign Enlargement of the Prostrate
- Study to Test the Efficacy and Safety of the Beta-3 Agonist YM178 in Patients With Symptoms of Overactive Bladder (ARIES)
- Safety and Efficacy of Escitalopram in the Treatment of Premature Ejaculation
- FTIH Study With GSK958108
